Neuroprotective and neurotrophic effects of lithium on bipolar disorder

Author/s
Cristian Vargas, Eduard Vieta, Carlos Lopez-Jaramillo
Citation
Issue 3 Summer 2013
CEPiP.2013;1:136-145
Abstract

Despite the development of other medications with mood-stabilising properties, such as atypical antipsychotics and antiepileptic drugs, lithium still remains the first-line treatment for bipolar disorder (BPD), and there is increasing evidence for the hypothesis of its neuroprotective and neurotrophic effects as key factors for its clinical effects.

Methods: A literature research was conducted using the PubMed database without chronological or language limits to August 2012. The following MESH terms were used: Bipolar Disorder and Lithium combined with: Neuroprotective, Neurotrophic, Neurocognitive effects, GSK-3b, bcl-2, BDNF, hippocampal. Original studies and reviews were selected (in vitro, in vivo and clinical studies).

Results: We found evidence in basic studies of neuroprotective and neurotrophic molecular pathways like GSK-3b, Bcl-2, BDNF, glutamate excitotoxicity, AP-1, mitochondrial dysfunction and neurosteroids. Several clinical studies in BPD show increased brain areas, reduced neuronal loss, reduced risk of dementia and one study showed improvement in neurocognitive function (verbal memory) associated with increased hippocampal size in lithium-treated groups versus controls, and other medications. The main areas were hippocampus (HC), anterior cingulate and prefrontal cortex (PFC). Functional Studies with N-Acetyl-aspartate (NAA) also support this hypothesis.

Conclusions: Despite basic, structural and functional evidence that shows neurotrophic and neuroprotective effect of lithium, longitudinal studies are needed to clarify the clinical relevance of these findings and their correlation with cognitive performance, which seems to be directly related with functional outcome.

Keywords: bipolar disorder, lithium, neuroprotective, neurotrophic, neurocognitive effects, GSK-3b, bcl-2, BDNF, hippocampal

Cite as: Cutting Edge Psychiatry in Practice 2013, 3(1):136-145; https://doi.org/10.65031/xjrz7365

References

  1. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012 Feb 25;379 (9817):721-8. https://doi.org/10.1016/s0140-6736(11)61516-x
  2. Nivoli AM, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology 2010;62 (1):27-35. https://doi.org/10.1159/000314307
  3. Bech P. The full story of lithium. A tribute to Mogens Schou (1918-2005). Psychother Psychosom 2006;75 (5):265-9.           
  4. Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 1999 Oct 1;46 (7):929-40. https://doi.org/10.1016/s0006-3223(99)00165-1
  5. Marmol F. [Lithium: 55 years of history in the therapy of bipolar affective disorder]. Med Clin (Barc ) 2006 Jul 1;127 (5):189-95.           
  6. Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 2008 Nov;18 (11):787-93. https://doi.org/10.1016/j.euroneuro.2008.07.005
  7. Hashimoto R, Fujimaki K, Jeong MR, Senatorov VV, Christ L, Leeds P, et al. [Neuroprotective actions of lithium]. Seishin Shinkeigaku Zasshi 2003;105 (1):81-6.
  8. Rowe MK, Chuang DM. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 2004 Oct 18;6 (21):1-18. https://doi.org/10.1017/s1462399404008385
  9. Li X, Ketter TA, Frye MA. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord 2002 May;69 (1-3):1-14. https://doi.org/10.1016/s0165-0327(00)00361-x
  10. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 1999;60 Suppl 2:27-39. https://doi.org/10.1097/00006842-199909000-00004
  11. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry 2011 Feb 15;69 (4):326-35. https://doi.org/10.1097/01.yic.0000405741.51457.8f
  12. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta- regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008 Sep;65 (9):1017-32. https://doi.org/10.1001/archpsyc.65.9.1017
  13. Chuang DM. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 2005 Aug;1053:195-204. https://doi.org/10.1196/annals.1344.018
  14. Kim HJ, Thayer SA. Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol 2009 May;75 (5):1021-30. https://doi.org/10.1124/mol.108.052357
  15. Kim JS, Chang MY, Yu IT, Kim JH, Lee SH, Lee YS, et al. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem 2004 Apr;89 (2):324-36. https://doi.org/10.1046/j.1471-4159.2004.02329.x
  16. Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Gasto C, et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000;69 (1):2-18. https://doi.org/10.1159/000012361
  17. Sole B, Bonnin CM, Torrent C, Martinez-Aran A, Popovic D, Tabares-Seisdedos R, et al. Neurocognitive impairment across the bipolar spectrum. CNS Neurosci Ther 2012 Mar;18 (3): 194-200. https://doi.org/10.1111/j.1755-5949.2011.00262.x
  18. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008 Nov;65 (11):1331-5. https://doi.org/10.1001/archpsyc.65.11.1331
  19. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010 Feb;12 (1):87-94. https://doi.org/10.1111/j.1399-5618.2009.00788.x
  20. Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry 2007 Apr;190:359-60. https://doi.org/10.1192/bjp.bp.106.029868
  21. Lauterbach EC, Mendez MF. Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research. J Neuropsychiatry Clin Neurosci 2011;23 (3):242-60. https://doi.org/10.1176/appi.neuropsych.23.3.242
  22. Pasquali L, Longone P, Isidoro C, Ruggieri S, Paparelli A, Fornai F. Autophagy, lithium, and amyotrophic lateral sclerosis. Muscle Nerve 2009 Aug;40 (2):173-94. https://doi.org/10.1002/mus.21423
  23. Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, Jr., et al. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 2006 Dec 1;66 (23):11179-86. https://doi.org/10.1158/0008-5472.can-06-2740
  24. Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl) 2007 Dec;195 (3):357-67. https://doi.org/10.1007/s00213-007-0906-9
  25. Manji HK, Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 2002;7 Suppl 1:S46-S56. https://doi.org/10.1038/sj.mp.4001018
  26. Mora A, Sabio G, Gonzalez-Polo RA, Cuenda A, Alessi DR, Alonso JC, et al. Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+ deprivation in cerebellar granule cells. J Neurochem 2001 Jul;78 (1):199-206. https://doi.org/10.1046/j.1471-4159.2001.00410.x
  27. Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008 Mar 5;28 (10):2576-88. https://doi.org/10.1523/jneurosci.5467-07.2008
  28. Li X, Bijur GN, Jope RS. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 2002 Apr;4 (2):137-44. https://doi.org/10.1034/j.1399-5618.2002.40201.x
  29. Machado-Vieira R, Manji HK, Zarate CA, Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009 Jun;11 Suppl 2:92-109. https://doi.org/10.1111/j.1399-5618.2009.00714.x
  30. Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999 Mar 5;274 (10):6039-42. https://doi.org/10.1074/jbc.274.10.6039
  31. Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 2000;61 Suppl 9:82-96.            
  32. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998 Aug 28;281 (5381):1322-6. https://doi.org/10.1126/science.281.5381.1322
  33. Bian Q, Shi T, Chuang DM, Qian Y. Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils. Brain Res 2007 Dec 12;1184:270-6. https://doi.org/10.1016/j.brainres.2007.09.054
  34. Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang DM. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 2002 Feb;80 (4):589-97. https://doi.org/10.1046/j.0022-3042.2001.00728.x
  35. Hashimoto R, Fujimaki K, Jeong MR, Christ L, Chuang DM. Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N-methyl-D- aspartate receptor-mediated excitotoxicity. FEBS Lett 2003 Mar 13;538 (1-3):145-8. https://doi.org/10.1016/s0014-5793(03)00167-4
  36. Quiroz JA, Machado-Vieira R, Zarate CA, Jr., Manji HK. Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 2010;62 (1):50-60. https://doi.org/10.1159/000314310
  37. Shaltiel G, Chen G, Manji HK. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 2007 Feb;7 (1):22-6. https://doi.org/10.1016/j.coph.2006.07.005
  38. Hunsberger J, Austin DR, Henter ID, Chen G. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci 2009;11 (3):333-48. https://doi.org/10.31887/dcns.2009.11.3/jhunsberger
  39. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998;21:127-48. https://doi.org/10.1146/annurev.neuro.21.1.127
  40. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009 Jan;14 (1):51-9. https://doi.org/10.1038/sj.mp.4002099
  41. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 2009 Sep;11 (6):663-71. https://doi.org/10.1111/j.1399-5618.2009.00733.x
  42. Suwalska A, Sobieska M, Rybakowski JK. Serum brain-derived neurotrophic factor in euthymic bipolar patients on prophylactic lithium therapy. Neuropsychobiology 2010;62 (4):229-34. https://doi.org/10.1159/000319949
  43. de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 2011 Apr 20;494 (1):54-6. https://doi.org/10.1016/j.neulet.2011.02.054
  44. Yuan PX, Chen G, Huang LD, Manji HK. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain Res Mol Brain Res 1998 Jul 15;58 (1-2):225-30. https://doi.org/10.1016/s0169-328x(98)00114-4
  45. Asghari V, Wang JF, Reiach JS, Young LT. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 1998 Jul 15;58 (1-2):95-102. https://doi.org/10.1016/s0169-328x(98)00107-7
  46. Shao L, Young LT, Wang JF. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 2005 Dec 1;58 (11):879-84. https://doi.org/10.1016/j.biopsych.2005.04.052
  47. Sun X, Wang JF, Tseng M, Young LT. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 2006 May;31 (3):189-96. https://doi.org/10.1139/jpn.0623
  48. Walz JC, Frey BN, Andreazza AC, Cereser KM, Cacilhas AA, Valvassori SS, et al. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J Psychiatr Res 2008 Apr;42 (5):416-21. https://doi.org/10.1016/j.jpsychires.2007.03.005
  49. Marx CE, Yuan P, Kilts JD, Madison RD, Shampine LJ, Manji HK. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol 2008 Jun;11 (4):547-52. https://doi.org/10.1017/s1461145708008444
  50. D’Mello SR, Anelli R, Calissano P. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 1994 Apr;211 (2):332-8. https://doi.org/10.1006/excr.1994.1095
  51. Nonaka S, Hough CJ, Chuang DM. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor- mediated calcium influx. Proc Natl Acad Sci U S A 1998 Mar 3;95 (5):2642-7. https://doi.org/10.1073/pnas.95.5.2642
  52. Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington’s disease. Mol Psychiatry 2004 Apr;9 (4):371-85. https://doi.org/10.1038/sj.mp.4001463
  53. Wei H, Qin ZH, Senatorov VV, Wei W, Wang Y, Qian Y, et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease. Neuroscience 2001;106 (3):603-12. https://doi.org/10.1016/s0306-4522(01)00311-6
  54. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000 Oct 7;356 (9237):1241-2. https://doi.org/10.1016/s0140-6736(00)02793-8
  55. Silverstone PH, Wu RH, O’Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003 Mar;18 (2):73-9. https://doi.org/10.1097/00004850-200303000-00002
  56. Lagace DC, Eisch AJ. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant? Psychiatr Clin North Am 2005 Jun;28 (2):399-414. https://doi.org/10.1016/j.psc.2005.02.002
  57. Bijur GN, De SP, Jope RS. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 2000 Mar 17;275 (11):7583-90. https://doi.org/10.1074/jbc.275.11.7583
  58. Nonaka S, Katsube N, Chuang DM. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998 Jul;286 (1):539-47. https://doi.org/10.1016/s0022-3565(24)37615-3
  59. Tseng WP, Lin-Shiau SY. Long-term lithium treatment prevents neurotoxic effects of beta- bungarotoxin in primary cultured neurons. J Neurosci Res 2002 Sep 1;69 (5):633-41. https://doi.org/10.1002/jnr.10318
  60. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? Biol Psychiatry 2000 Jul 1;48 (1):1-8. https://doi.org/10.1016/s0006-3223(00)00252-3
  61. Hajek T, Bauer M, Pfennig A, Cullis J, Ploch J, O’Donovan C, et al. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci 2012 May;37 (3):185-92. https://doi.org/10.1503/jpn.110097
  62. Forester BP, Finn CT, Berlow YA, Wardrop M, Renshaw PF, Moore CM. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 2008 Sep;10 (6):691-700. https://doi.org/10.1111/j.1399-5618.2008.00627.x
  63. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ, et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002 Aug 30;329 (2):243-5. https://doi.org/10.1016/s0304-3940(02)00615-8
  64. Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, Nicoletti M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 2007 Jul 1;62 (1): 7-16. https://doi.org/10.1016/j.biopsych.2006.10.027
  65. Bearden CE, Thompson PM, Dutton RA, Frey BN, Peluso MA, Nicoletti M, et al. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 2008 May;33 (6):1229-38. https://doi.org/10.1038/sj.npp.1301507
  66. Yucel K, Taylor VH, McKinnon MC, Macdonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 2008 Jan;33 (2):361-7. https://doi.org/10.1038/sj.npp.1301405
  67. van Erp TG, Thompson PM, Kieseppa T, Bearden CE, Marino AC, Hoftman GD, et al. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum Brain Mapp 2012 Mar;33 (3):501-10. https://doi.org/10.1002/hbm.21239
  68. Baykara B, Inal-Emiroglu N, Karabay N, Cakmakci H, Cevher N, Senturk PB, et al. Increased hippocampal volumes in lithium treated adolescents with bipolar disorders: a structural MRI study. J Affect Disord 2012 May;138 (3):433-9. https://doi.org/10.1016/j.jad.2011.12.047
  69. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Reus GZ, et al. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 2006 Jun;17 (4):311-8. https://doi.org/10.1097/01.fbp.0000205013.59455.09
  70. Hajek T, Cullis J, Novak T, Kopecek M, Hoschl C, Blagdon R, et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord 2012 May;14 (3):261-70. https://doi.org/10.1111/j.1399-5618.2012.01013.x
  71. Germana C, Kempton MJ, Sarnicola A, Christodoulou T, Haldane M, Hadjulis M, et al. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand 2010 Dec;122 (6):481-7. https://doi.org/10.1111/j.1600-0447.2010.01582.x
  72. Hajek T, Kopecek M, Hoschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci 2012 Sep;37 (5):333-43. https://doi.org/10.1503/jpn.110143
  73. Eriksson PS. Neurogenesis and its implications for regeneration in the adult brain. J Rehabil Med 2003 May; (41 Suppl):17-9.               
  74. Kempermann G, Gage FH. Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal. Hippocampus 1999;9 (3):321-32. https://doi.org/10.1002/(sici)1098-1063(1999)9:3<321::aid-hipo11>3.0.co;2-c
  75. Gould E, Reeves AJ, Graziano MS, Gross CG. Neurogenesis in the neocortex of adult primates. Science 1999 Oct 15;286 (5439):548-52. https://doi.org/10.1126/science.286.5439.548
  76. Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997 Jan 30;385 (6615):434-9. https://doi.org/10.1038/385434a0
  77. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010 Jul;35 (8):1743-50. https://doi.org/10.1038/npp.2010.41
  78. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 2009 May;70 (5):699-705. https://doi.org/10.4088/jcp.07m03745
  79. Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M, et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. 145 Neurosci Lett 2007 Dec 11;429 (1):7-11. https://doi.org/10.1016/j.neulet.2007.09.074
  80. Brambilla P, Stanley JA, Sassi RB, Nicoletti MA, Mallinger AG, Keshavan MS, et al. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004 Oct;29 (10):1918-24. https://doi.org/10.1038/sj.npp.1300520
  81. Rametti A, Esclaire F, Yardin C, Cogne N, Terro F. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection. Neurosci Lett 2008 Mar 21;434 (1):93-8. https://doi.org/10.1016/j.neulet.2008.01.034
  82. Toledo EM, Inestrosa NC. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer’s disease. Mol Psychiatry 2010 Mar;15 (3):272-85, 228. https://doi.org/10.1038/mp.2009.72
  83. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2008 Feb 12;105 (6):2052-7. https://doi.org/10.1073/pnas.0708022105
  84. Fornai F, Longone P, Ferrucci M, Lenzi P, Isidoro C, Ruggieri S, et al. Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium. Autophagy 2008 May;4 (4):527-30. https://doi.org/10.4161/auto.5923
  85. Lopez-Jaramillo C, Lopera-Vasquez J, Ospina-Duque J, Garcia J, Gallo A, Cortez V, et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 2010 Aug;71 (8):1055-60. https://doi.org/10.4088/jcp.08m04673yel
  86. Vargas C, Correa-Palacio A, Garcia J, Lopez-Jaramillo C. Resonancia Magnetica funcional en pacientes adultos eutimicos con trastorno bipolar tipo I: Una vision neuropsicologica y neurofuncional. Revista Colombiana de Psiquiatria 2011;40 (suplemento 2011):183-97. https://doi.org/10.1016/s0034-7450(14)60202-x
  87. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006 Jul;93 (1-3): 105-15. https://doi.org/10.1016/j.jad.2006.02.016
  88. Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005 Jan;186:32-40. https://doi.org/10.1192/bjp.186.1.32
  89. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 2007 Jul;68 (7): 1078-86. https://doi.org/10.4088/jcp.v68n0715
  90. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry 2008 May;69 (5):712-9. https://doi.org/10.4088/jcp.v69n0504
  91. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; (434):17-26. https://doi.org/10.1111/j.1600-0447.2007.01055.x
  92. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007 Feb;9 (1-2):103-13. https://doi.org/10.1111/j.1399-5618.2007.00327.x
  93. Tabares-Seisdedos R, Balanza-Martinez V, Sanchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord 2008 Aug;109 (3):286-99. https://doi.org/10.1016/j.jad.2007.12.234
  94. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009 Nov;70 (11):1588-97. https://doi.org/10.4088/jcp.08r04972
  95. Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007 Oct 15;62 (8):894-900. https://doi.org/10.1016/j.biopsych.2007.03.005
  96. Sassi RB, Brambilla P, Hatch JP, Nicoletti MA, Mallinger AG, Frank E, et al. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 2004 Oct 1;56 (7):467-75. https://doi.org/10.1016/j.biopsych.2004.07.005
  97. Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopoulos P, Kaprinis G, et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int J Neuropsychopharmacol 2008 Mar;11 (2):269-87. https://doi.org/10.1017/s1461145707007821
  98. Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 2010 Feb;121 (1-2):156-60. https://doi.org/10.1016/j.jad.2009.05.014
  99. van PH, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional neurogenesis in the adult hippocampus. Nature 2002 Feb 28;415 (6875):1030-4. https://doi.org/10.1038/4151030a
  100. Chepenik LG, Wang F, Spencer L, Spann M, Kalmar JH, Womer F, et al. Structure-function associations in hippocampus in bipolar disorder. Biol Psychol 2012 Apr;90 (1):18-22. https://doi.org/10.1016/j.biopsycho.2012.01.008
  101. Hackert VH, den HT, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM. Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 2002 Nov;17 (3):1365-72. https://doi.org/10.1006/nimg.2002.1248